TY  - GEN 
AU  - Medina Moreno, Ana
AU  - El-Hammadi, Mazen M.
AU  - Arias Mediano, José Luis
PY  - 2023
UR  - https://hdl.handle.net/10481/83905
AB  - Tegafur is used to treat various malignant lesions, including advanced gastric and colorectal cancers. However,
its efficacy is limited by its low oral bioavailability, short half-life and serious toxicity. To address these drawbacks,
a...
LA  - eng
PB  - Elsevier
KW  - Poly(ε-caprolactone)
KW  - Chitosan
KW  - Tegafur
KW  - Nanoparticles
KW  - Colorectal cancer
KW  - Drug delivery
TI  - pH-dependent, extended release and enhanced in vitro efficiency against colon cancer of Tegafur formulated using chitosan-coated poly (ε-caprolactone) nanoparticles
DO  - 10.1016/j.jddst.2023.104594
ER  -